CT lung screening risk models optimize nodule management
Risk prediction models can differentiate between benign and malignant nodules...Read more on AuntMinnie.comRelated Reading: Mobile CT improves access to lung cancer screening Findings from NELSON trial affirm benefits of CT lung screening Life expectancy model refines CT lung screening criteria Risk model improves accuracy of CT lung cancer screening Risk model predicts malignancy of lung nodules on CT
Conclusion: The mSHOX2/mPTGER4 assay showed some values with more limitations in lung cancer early detection. PMID: 32250153 [PubMed - as supplied by publisher]
We report a very rare case of multiple solitary necrotic nodules of the liver mimicking hepatic metastases in a patient with previous history of lung cancer. The lesions appeared as low-attenuated or low-signal intensity nodules with thin rim enhancement on both contrast-enhanced computed tomography (CT) and magnetic resonance (MR) imaging, making them difficult to differentiate from hepatic metastases. This rare benign entity should be kept in mind, especially when lesions are small and located in the subcapsular areas of the liver. Published on 2020-04-07 11:34:44
Conclusions L-SURmax showed the most powerful predictive performance than the other PET parameters in predicting occult lymph node metastasis. The combination of three independent risk factors (carcinoembryonic antigen, cytokeratin 19 fragment, and L-SURmax) can effectively predict occult lymph node metastasis in clinical N0 non–small cell lung cancer patients.
Publication date: Available online 6 April 2020Source: Journal of the American Society of CytopathologyAuthor(s): Rachel Jug, Coral X. Giovacchini, Beiyu Liu, Cindy Green, Jeffrey M. Clarke, Kamran Mahmood, Elizabeth N. Pavlisko
Lung cancer is more common in never smokers who have chronic obstructive pulmonary disease (COPD) than in ever smokers without COPD, concludes an observational study.Medscape Medical News
Lung cancer experts issued thoughtful recommendations on how to approach lung cancer during the pandemic while still limiting exposure to COVID-19 as patients are in hospital receiving treatment.Medscape Medical News
Publication date: Available online 6 April 2020Source: Journal of Molecular StructureAuthor(s): Saravanan Kandasamy, Prabhu Subramani, Selvi Subramani, John marshal Jayaraj, Gunasekaran Prasanth, Kannupal Srinivasan, Karthikeyan Muthusamy, Venkatachalam Rajakannan, Ravikumar Vilwanathan
No abstract available
npj Primary Care Respiratory Medicine, Published online: 07 April 2020; doi:10.1038/s41533-020-0173-3Predictive values of lung cancer alarm symptoms in the general population: a nationwide cohort study
Cancers, Vol. 12, Pages 896: Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET Cancers doi: 10.3390/cancers12040896 Authors: Tamminga Andree Hiltermann Jayat Schuuring van den Bos Spierings Lansdorp Timens Terstappen Groen Circulating tumor cells (CTCs) detected by CellSearch are prognostic in non-small-cell lung cancer (NSCLC), but rarely found. CTCs can be extracted from the blood together with mononuclear cell populations by diagnostic leukapheresis (DLA), therefore concentrating th...